Institutional Ownership Prelude Therapeutics Inc (PRLD)
This table provides information about the institutional ownership of Prelude Therapeutics Inc (PRLD). We have compiled data on the 71 institutions that hold shares in the stock, with a total of 35.7 Million shares, which have been reported (via 13F filing form) to have a value of $34.3 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
10,909,256
shares
|
$10.5 Million
0.53% of portfolio
|
Q2 2023
Added 8.66%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Nov 14, 2024 Q3 2024 |
10,123,824
shares
|
$9.72 Million
0.22% of portfolio
|
Q1 2021
Added 0.05%
|
|
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
Nov 14, 2024 Q3 2024 |
3,766,120
shares
|
$3.62 Million
0.14% of portfolio
|
Q3 2024
Reduced 8.88%
|
|
|
Boxer Capital, LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
1,708,187
shares
|
$1.64 Million
0.19% of portfolio
|
Q3 2024
Reduced 33.49%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
1,097,599
shares
|
$1.05 Million
0.0% of portfolio
|
Q3 2024
Added 23.15%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
1,068,916
shares
|
$1.03 Million
0.0% of portfolio
|
Q2 2024
Reduced 2.6%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
1,021,770
shares
|
$980,899
0.0% of portfolio
|
Q3 2024
Added 1.11%
|
|
|
Exodus Point Capital Management, LP
New York, NY |
Nov 12, 2024 Q3 2024 |
921,621
shares
|
$884,756
0.01% of portfolio
|
Q3 2024
New holding
|
|
|
Avidity Partners Management LP
Dallas, TX |
Nov 14, 2024 Q3 2024 |
890,000
shares
|
$854,400
0.11% of portfolio
|
Q3 2024
New holding
|
|
|
Massachusetts Financial Services CO
Boston, MA |
Nov 12, 2024 Q3 2024 |
549,530
shares
|
$527,548
0.0% of portfolio
|
Q3 2024
Added 5.2%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
391,716
shares
|
$376,047
0.0% of portfolio
|
Q3 2024
Added 8.22%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
359,137
shares
|
$344,771
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
323,689
shares
|
$310,741
0.0% of portfolio
|
Q3 2024
Added 12.64%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
286,046
shares
|
$274,604
0.0% of portfolio
|
Q3 2024
Added 35.09%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
281,583
shares
|
$270,319
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
196,900
shares
|
$189,024
0.0% of portfolio
|
Q3 2024
Reduced 4.7%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Nov 14, 2024 Q3 2024 |
176,100
shares
|
$169,056
0.01% of portfolio
|
Q3 2024
Added 42.48%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 14, 2024 Q3 2024 |
174,979
shares
|
$167,979
0.0% of portfolio
|
Q3 2024
Added 885.19%
|
|
|
Td Asset Management Inc
|
Nov 01, 2024 Q3 2024 |
160,652
shares
|
$154,225
0.0% of portfolio
|
Q3 2023
Added 100.0%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
160,524
shares
|
$154,103
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
133,249
shares
|
$127,919
0.0% of portfolio
|
Q3 2024
Added 4.07%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
106,377
shares
|
$102,121
0.0% of portfolio
|
Q3 2024
Reduced 14.68%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
95,161
shares
|
$91,354
0.0% of portfolio
|
Q3 2024
Added 27.01%
|
|
|
Walleye Capital LLC
Plymouth, MN |
Nov 14, 2024 Q3 2024 |
83,175
shares
|
$79,848
0.0% of portfolio
|
Q3 2024
Added 446.16%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
74,143
shares
|
$71,177
0.0% of portfolio
|
Q3 2024
Added 235.34%
|